David ShaywitzOvjeren akaunt

@DShaywitz

MD,PhD;Founder, Astounding HealthTech-Advisory Services, supporting drug developers; TechTonics (bk, pcast). Not engaged on twitter/broadcast only (via )

Bay area
Vrijeme pridruživanja: listopad 2011.

Medijski sadržaj

  1. I realize I'm only seven years late to this exceptional, poignant video via Dr. Toby Cosgrove h/t about the centrality of empathy in medicine and healthcare. - it's a beautiful short video and will deeply resonate with all.

  2. Initial word is that problematic Iowa app issues consequence of building in extra security protections which made app unwieldy to use in practice. Reminded of this outstanding episode feat , entitled "cautionary tales"

  3. 3. velj

    Re: new podcast w , health data oncologist who used to be , now is (): key point he makes, echoing one I've heard from others at health/tech interface, is the critical need to lose the vendor mindset for tech partners

  4. 3. velj

    Gr8 new feat , who shares his captivating journey, from fleeing Iran after Revolution to pursuing medicine+technology in the U.S., recently & now at - all while maintaining his passion for music.

  5. 29. sij

    Must-read, describing experiences of as he tries to get own hlth records (unsuccessfully), & has his meds misrecorded- i.e. the usual. He also lambasts anti-interop of certain EHR co's. Resonates w/recent

  6. 27. sij

    Passionate by + ripping Epic's 11th hr opposition to interop. If only AMCs had some way to influence a co like Epic....Cynic would say Epic enables AMC docs to honestly plead for interop, yet serving AMC CFOs by forestalling it

  7. 27. sij

    As nicely summarizes, I'm "not as pessimistic abt tech as many emerging critics of Silicon Valley. But [I'm] listening 2what critics have 2say, & seeing ways in which today's debate can contribute to a better future in the area of healthtech"

  8. 27. sij

    Latest Astounding HealthTech Techlash challenges assumptions of tech's inevitability-a good thing. +Why, given choice betw Siebel's digital transformation (~panopticon FTW) & "Surveillance Capitalism," I vote for ...

  9. 24. sij

    Powerful (and 100% apolitical) essay highlighting just how deeply and fundamentally uncertain so much of medicine remains - more than rule than the exception, I suspect. cc

  10. 23. sij

    At yesterday, Brook Byers, like many, praised direction of towards seeking improved tech and considering approvals in light of risk and need. He also called out concerning recent NYT op-ed expressing hope approvals slow down.

  11. 23. sij

    In the same way gets the most consistently amazing biopharma guests for The Long Run pcast (), so impressed with health systems guests on , . Latest show GREAT!

  12. 22. sij

    Relevant interoperability slides at from cc

  13. 22. sij

    Great 2b at Silicon Valley where I’m privileged to both MC AI+Data Science track, & moderate afternoon panel on data viz & mining feat + leaders from . Great 2c

  14. 22. sij

    1/2 Outstanding article by abt challenges tech co's, esp Google, face in health arena. Feat smart quotes from & among others. I thought entrepreneur nailed it by noting...

  15. 20. sij

    Love this new , featuring Matthew DeSilva of . Poignant discussion of Matt's journey from a quant working for Peter Thiel's Clarium Capital to head of a personalized medicine lab and company. cc

  16. 17. sij

    This is a how a digital transformation protagonist envisions the tech revolution improving our healthcare future... seems important to decide if such comprehensive continuous surveillance is worth anticipated benefits—assume such benefits even materialize

  17. 17. sij

    As every business is pushed to urgently undertake a “digital transformation,” I thought it might be helpful to understand more about the ideology behind this mandate, as well as to examine anticipated implications for healthcare and for businesses.

  18. 17. sij

    "Digital Transformation" is ideology of the moment in business. What does this actually mean? In my latest Astounding HealthTech column , I review basic tenets lays out, & discuss implications for biopharma/HC, and for org change

  19. 16. sij

    Just wrote abt contrasting but related approaches Atomwise & EQRx taking to R&D inefficiency: . Thoughtful read, worth ur time. But then please read 's en fuego take on EQRx ; my fav graf below.

  20. 15. sij

    Good insights panel Karan Arora, dig --Need dig hlth tools 2b easy+understandable (no blk box);HC already so complx -Must b sustainable frm behav POV -big tech players providing general tools, but not [bespoke] endpt solns

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·